205 related articles for article (PubMed ID: 11893104)
21. [Regulations and lymphadenectomy strategy of mediastinal and upper abdominal lymph node metastasis in thoracic esophageal carcinoma].
Xue HC; Wu CR; Zhang ZB; Zhu ZH; Ma ZK; Gao J
Ai Zheng; 2007 Sep; 26(9):1020-4. PubMed ID: 17927865
[TBL] [Abstract][Full Text] [Related]
22. Prognostic factors of curatively resected esophageal carcinoma associated with multiple metastatic lymph nodes.
Tabira Y; Sakaguchi T; Yoshida Y; Kuhara H; Kawasuji M
Hepatogastroenterology; 2006; 53(71):715-9. PubMed ID: 17086875
[TBL] [Abstract][Full Text] [Related]
23. Outcome of oesophagectomy for adenocarcinoma of the oesophagus and oesophagogastric junction.
Zhang X; Watson DI; Jamieson GG; Lally C; Bessell JR; Devitt PG
ANZ J Surg; 2005 Jul; 75(7):513-9. PubMed ID: 15972033
[TBL] [Abstract][Full Text] [Related]
24. Factors predictive of prognosis after esophagectomy for squamous cell cancer.
Li H; Zhang Q; Xu L; Chen Y; Wei Y; Zhou G
J Thorac Cardiovasc Surg; 2009 Jan; 137(1):55-9. PubMed ID: 19154903
[TBL] [Abstract][Full Text] [Related]
25. En bloc vs transhiatal esophagectomy for stage T3 N1 adenocarcinoma of the distal esophagus.
Johansson J; DeMeester TR; Hagen JA; DeMeester SR; Peters JH; Oberg S; Bremner CG
Arch Surg; 2004 Jun; 139(6):627-31; discussion 631-3. PubMed ID: 15197089
[TBL] [Abstract][Full Text] [Related]
26. Prediction of lymph node status in superficial esophageal carcinoma.
Ancona E; Rampado S; Cassaro M; Battaglia G; Ruol A; Castoro C; Portale G; Cavallin F; Rugge M
Ann Surg Oncol; 2008 Nov; 15(11):3278-88. PubMed ID: 18726651
[TBL] [Abstract][Full Text] [Related]
27. Curative effect comparison between Ivor-Lewis esophagectomy and left transthoracic esophagectomy in treatment of middle thoracic esophagus carcinoma.
Song L; Liu Y; Wang Z; Ren WG; Liu XY
Hepatogastroenterology; 2012 May; 59(115):738-41. PubMed ID: 22024231
[TBL] [Abstract][Full Text] [Related]
28. Location and clinical impact of solitary lymph node metastasis in patients with thoracic esophageal carcinoma.
Shimada H; Okazumi S; Matsubara H; Nabeya Y; Shiratori T; Shuto K; Shimizu T; Akutsu Y; Tanizawa Y; Hayashi H; Ochiai T
Am J Surg; 2006 Sep; 192(3):306-10. PubMed ID: 16920423
[TBL] [Abstract][Full Text] [Related]
29. [The local control of radiotherapy following Ivor-Lewis esophagectomy in the patients with stage II A middle-third thoracic esophageal cancer].
Zhang MY; Wang Z; Liu XY; Chen G; Liu FY
Zhonghua Wai Ke Za Zhi; 2008 Jul; 46(14):1048-50. PubMed ID: 19094527
[TBL] [Abstract][Full Text] [Related]
30. Neoadjuvant chemoradiotherapy for locally advanced esophageal cancer: experience at a single institution.
Malaisrie SC; Untch B; Aranha GV; Mohideen N; Hantel A; Pickleman J
Arch Surg; 2004 May; 139(5):532-8; discussion 538-9. PubMed ID: 15136354
[TBL] [Abstract][Full Text] [Related]
31. Impact of lymph node involvement in T2 or T3 thoracic esophageal squamous cell carcinoma.
Shimada H; Okazumi S; Shiratori T; Akutsu Y; Matsubara H
Hepatogastroenterology; 2009; 56(93):1039-43. PubMed ID: 19760937
[TBL] [Abstract][Full Text] [Related]
32. Clinicopathologic features of superficial esophageal cancer: results of consecutive 100 patients.
Tachibana M; Hirahara N; Kinugasa S; Yoshimura H
Ann Surg Oncol; 2008 Jan; 15(1):104-16. PubMed ID: 17891442
[TBL] [Abstract][Full Text] [Related]
33. En bloc esophagectomy reduces local recurrence and improves survival compared with transhiatal resection after neoadjuvant therapy for esophageal adenocarcinoma.
Rizzetto C; DeMeester SR; Hagen JA; Peyre CG; Lipham JC; DeMeester TR
J Thorac Cardiovasc Surg; 2008 Jun; 135(6):1228-36. PubMed ID: 18544359
[TBL] [Abstract][Full Text] [Related]
34. Have surgical outcomes of pathologic T4 esophageal squamous cell carcinoma really improved? Analysis of 268 cases during 45 years of experience.
Shimada H; Shiratori T; Okazumi S; Matsubara H; Nabeya Y; Shuto K; Akutsu Y; Hayashi H; Isono K; Ochiai T
J Am Coll Surg; 2008 Jan; 206(1):48-56. PubMed ID: 18155568
[TBL] [Abstract][Full Text] [Related]
35. Neoadjuvant chemoradiation versus chemotherapy for patients undergoing esophagectomy for esophageal cancer.
Luu TD; Gaur P; Force SD; Staley CA; Mansour KA; Miller JI; Miller DL
Ann Thorac Surg; 2008 Apr; 85(4):1217-23; discussion 1223-4. PubMed ID: 18355499
[TBL] [Abstract][Full Text] [Related]
36. Prognostic factors for the survival of patients with esophageal carcinoma in the U.S.: the importance of tumor length and lymph node status.
Eloubeidi MA; Desmond R; Arguedas MR; Reed CE; Wilcox CM
Cancer; 2002 Oct; 95(7):1434-43. PubMed ID: 12237911
[TBL] [Abstract][Full Text] [Related]
37. Multifocal neoplasia and nodal metastases in T1 esophageal carcinoma: implications for endoscopic treatment.
Altorki NK; Lee PC; Liss Y; Meherally D; Korst RJ; Christos P; Mazumdar M; Port JL
Ann Surg; 2008 Mar; 247(3):434-9. PubMed ID: 18376186
[TBL] [Abstract][Full Text] [Related]
38. Surgical treatment for locally advanced (T4) squamous cell carcinoma of the thoracic esophagus.
Tachibana M; Dhar DK; Kinugasa S; Yoshimura H; Shibakita M; Ohno S; Ueda S; Fujii T; Kohno H; Nagasue N
Dysphagia; 2002; 17(4):255-61. PubMed ID: 12355140
[TBL] [Abstract][Full Text] [Related]
39. Esophageal carcinoma. Improved quality of survival with resection.
Bluett MK; Sawyers JL; Healy D
Am Surg; 1987 Mar; 53(3):126-32. PubMed ID: 2435199
[TBL] [Abstract][Full Text] [Related]
40. Staging of esophageal carcinoma: length of tumor and number of involved regional lymph nodes. Are these independent prognostic factors?
Bollschweiler E; Baldus SE; Schröder W; Schneider PM; Hölscher AH
J Surg Oncol; 2006 Oct; 94(5):355-63. PubMed ID: 16967455
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]